Pacira BioSciences (PCRX) Competitors

Pacira BioSciences (NASDAQ:PCRX) and Perrigo (NYSE:PRGO) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, community ranking, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Do analysts recommend PCRX or PRGO?

Pacira BioSciences currently has a consensus price target of $26.67, indicating a potential upside of 7.18%. Perrigo has a consensus price target of $33.00, indicating a potential upside of 31.78%. Given Perrigo's higher probable upside, analysts plainly believe Perrigo is more favorable than Pacira BioSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pacira BioSciences	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33
Perrigo	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25

Is PCRX or PRGO more profitable?

Perrigo has a net margin of -3.64% compared to Pacira BioSciences' net margin of -13.07%. Pacira BioSciences' return on equity of 13.42% beat Perrigo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pacira BioSciences	-13.07%	13.42%	7.19%
Perrigo	-3.64%	7.38%	3.18%

Which has preferable earnings and valuation, PCRX or PRGO?

Pacira BioSciences has higher earnings, but lower revenue than Perrigo. Perrigo is trading at a lower price-to-earnings ratio than Pacira BioSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pacira BioSciences	$700.97M	1.64	$41.96M	-$2.19	-11.36
Perrigo	$4.37B	0.78	-$12.70M	-$1.25	-20.03

Which has more volatility & risk, PCRX or PRGO?

Pacira BioSciences has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Comparatively, Perrigo has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500.

Does the media refer more to PCRX or PRGO?

In the previous week, Pacira BioSciences had 3 more articles in the media than Perrigo. MarketBeat recorded 16 mentions for Pacira BioSciences and 13 mentions for Perrigo. Perrigo's average media sentiment score of 1.43 beat Pacira BioSciences' score of 0.71 indicating that Perrigo is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pacira BioSciences	8 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Perrigo	11 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders believe in PCRX or PRGO?

99.7% of Pacira BioSciences shares are owned by institutional investors. Comparatively, 95.9% of Perrigo shares are owned by institutional investors. 6.4% of Pacira BioSciences shares are owned by insiders. Comparatively, 0.7% of Perrigo shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Does the MarketBeat Community prefer PCRX or PRGO?

Pacira BioSciences received 59 more outperform votes than Perrigo when rated by MarketBeat users. Likewise, 71.55% of users gave Pacira BioSciences an outperform vote while only 66.35% of users gave Perrigo an outperform vote.

Company	Underperform	Outperform
Pacira BioSciences	Outperform Votes 830 71.55%	Underperform Votes 330 28.45%
Perrigo	Outperform Votes 771 66.35%	Underperform Votes 391 33.65%

Summary

Pacira BioSciences beats Perrigo on 13 of the 18 factors compared between the two stocks.